Skip to content
Open access

Late diagnosis of SCN1A-associated Dravet syndrome in an adult with drug-resistant epilepsy

Oct 2026 · ANPAbstract_CBN26 · 0 citations

TL;DR

Functional neuroimaging findings supported the presence of a right temporal epileptogenic focus, even in the absence of an evident structural lesion on magnetic resonance imaging, in a male patient with onset of epileptic seizures at 11 months of age.

Abstract

Case Presentation: A male patient, 36 years old, with onset of epileptic seizures at 11 months of age. The first episode was characterized by a left focal motor seizure, progressing to cyanosis and requiring emergency medical care. After this event, he began to experience recurrent and frequent seizures, predominantly during sleep, with different semiological manifestations, including eyelid blepharospasm, hypoxic-ischemic encephalopathy, hypersalivation, and focal seizures evolving to bilateral tonic-clonic seizures. Premonitory signs before seizures and triggering factors, such as physical exertion or emotional excitement, were reported, resulting in significant limitations in daily activities. Over the course of the disease, the patient developed progressive cognitive impairment and drug-resistant epilepsy, with multiple hospitalizations due to status epilepticus. Functional studies demonstrated hypoperfusion and hypometabolism in the right temporal pole, suggesting an epileptogenic focus. A genetic panel identified a heterozygous pathogenic variant in the SCN1A gene (p.Arg393Cys), confirming the diagnosis of Dravet syndrome at 30 years of age. The patient had used multiple antiseizure medications throughout life without adequate seizure control and underwent neuromodulation with vagus nerve stimulation. Subsequently, gradual tapering of sodium valproate was performed, with the introduction of lacosamide, resulting in a transient exacerbation of seizures during the process and the need for therapeutic adjustments. Discussion: Dravet syndrome is an epileptic encephalopathy associated with pathogenic variants in the SCN1A gene and is characterized by early seizure onset, progression to drug resistance, and impairment of neurocognitive development. Genetic confirmation clarified the etiology of the epilepsy after decades of clinical evolution. Functional neuroimaging findings further supported the presence of a right temporal epileptogenic focus, even in the absence of an evident structural lesion on magnetic resonance imaging. Final Comments: This case highlights the importance of genetic investigation in early-onset and difficult-to-control epilepsies, even in adult patients. An atypical clinical presentation may delay the diagnosis of Dravet syndrome, underscoring the role of genetic testing in clarifying the etiology and guiding therapeutic management.

Read PDF

Similar papers

Open access Oct 2026

Dravet syndrome associated with SCN1A mutation: case report with therapeutic response to cannabidiol

Case Presentation: Dravet syndrome is a rare developmental and epileptic encephalopathy characterized by early-onset drug-resistant seizures and progressive neurological deterioration. Most cases are associated with SCN1A mutations, which encode the neuronal sodium channel NaV1.1, essential for inhibitory GABAergic int...

Carlos Eduardo Mendonça Oliveira, H. Siqueira, Hingrid Cristine Arruda Oliveira et al. · 0 citations
Open access Oct 2026

Refractory epilepsy and involuntary movements associated with SCN8A mutation: a case report of early-onset developmental and epileptic encephalopathy

Case Presentation: A 15-month-old female infant, with no relevant family history and an uneventful gestation, presented with focal epileptic seizures at two months of age, one day after vaccination. The patient developed refractory epilepsy characterized by tonic and clonic seizures with secondary generalization, frequ...

Beatriz Malbouisson Menezes, Thulio Carvalho Morais, Cristiane Maria Rocha · 0 citations
Open access Oct 2026

Diagnostic delay in SCN8A-related developmental and epileptic encephalopathy: clinical impact of genetic testing in early-onset drug-resistant epilepsy

Case Presentation: 17-year-old female with seizure onset at four weeks of life was evaluated for long-standing drug-resistant epilepsy. Initial seizures consisted of vertical head movements evolving to tonic–clonic extension of two limbs with ocular and cephalic deviation to the right, followed by tonic extension of al...

M. Boff, J. Zambeli, Fernanda Noschang da Rocha Colcete et al. · 0 citations
Open access Oct 2026

Pathogenic KCNQ5 variant in a patient with severe epilepsy and neurodevelopmental disorder: a case report with neuromodulatio

Case Presentation: Patient B.V.T.T., male, 12 years old, with autism spectrum disorder, neurodevelopmental delay, and epilepsy onset at 4 years and 2 months of age. From the beginning, he presented photosensitivity and absence seizures, later progressing to frequent generalized tonic-clonic seizures, with an average of...

Hadassa Tonussi Rossette Do Valle Tonussi, Sabrina da Silva Oliveira, Marcus Vinícius Guirado Teixeira Guirado et al. · 0 citations
Open access Oct 2026

Favorable outcome in drug-resistant epilepsy with myoclonic-atonic seizures after cannabidiol introduction: a case report

Case Presentation: A previously healthy male patient developed afebrile generalized tonic-clonic seizures at 3 years and 7 months of age. Over the following months, he evolved with multiple seizure types, including daily absence seizures and myoclonic-atonic seizures with drop attacks, leading to falls and head trauma....

Eduarda Franceschet, Anita Ferreira das Neves, Jôsefi Augusto de Almeida Corrêa et al. · 0 citations
Open access Oct 2026

Status epilepticus in epileptic encephalopathy associated with TBC1D24 gene

Case Presentation: A 19-year-old female patient from Porto Alegre, Rio Grande do Sul, was admitted to the emergency department with status epilepticus in July 2025. History of neuropsychomotor developmental delay in the context of genetic epileptic encephalopathy, confirmed by genetic testing performed at two different...

P. Romano, Matheos Pezzi, Ana Luiza Reusing Pacheco et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.